统一服务热线:400-888-0207 在线咨询 | 微信联系
首页 > 产品 > 产品类型 > 试剂盒 > 免疫检测试剂盒
SARS-CoV-2 sVNT/COVID-19 sVNT
货号:EL-1611-32214 | 规格:96 wells | 价格:¥13584.00 | 品牌:AffinityImmuno
SARS-CoV-2 surrogate Virus Neutralizing Test (sVNT) (spike protein/ ACE2 ligand binding assay) COVID-19 sVNTSARS-CoV-2替代病毒中和测试(sVNT)(spike蛋白/ACE2配体结合检测)COVID-19 sVNT 是由北京中昊新生科技有限公司提供,AffinityImmuno产品包括ELISA试剂盒和单克隆抗体,提供定制鸡多克隆抗体的服务。AffinityImmuno Inc.针对COVID 19大流行推出了一系列试剂,其中包括各种多克隆抗体、病毒刺突蛋白ELISA试剂盒和病毒

SARS-CoV-2替代病毒中和测试(sVNT)(spike蛋白/ACE2配体结合检测)COVID-19 sVNT
SARS-CoV-2 surrogate Virus Neutralizing Test (sVNT) (spike protein/ ACE2 ligand binding assay) COVID-19 sVNT


AffinityImmuno Inc.’s SARS-CoV-2 spike protein-ligand binding assay (surrogate Virus Neutralization Test) allows rapid quantification of COVID-19 neutralizing antibodies in serum and plasma by measuring the reduction in binding of viral spike protein with its receptor ACE2. This assay allows rapid analysis of convalescent plasma, antibody-based therapeutics, vaccine leads, and immune response to the virus to measure the percent reduction in spike protein binding to ACE2. This serological platform was designed as a tool to understand the correlation between neutralizing antibody level and protective immunity in recovered SARS-CoV-2.


This product helps to identify the presence of SARS-CoV-2 / COVID-19 neutralizing antibodies via surrogate virus neutralization testing (SVNT). This process is able to be conducted quickly in comparison to other detection methods such as Plaque Reduction Neutralization Test (PRNT) or similar cell culture based tests that take multiple days to perform. The AffinityImmuno sVNT test has a number of applications including convalescent plasma screening, vaccine response testing, small molecule ligand screening, and monitoring population immunity that could help to combat the global SARS-CoV-2 / COVID-19 pandemic.

sVNT-serum-data-800x736.jpeg

Comparison of 62 serum samples from recovered, COVID-19 individuals to 260 non-COVID-19 (self-declared) individuals demonstrates the presence of virus neutralizing antibodies that prevent binding between the spike protein and its receptor, ACE2.

相关产品
相关资料